Autism and Communication |
|
|
Clinical Trial: Childhood Autism Risks from Genetics and the Environment (The CHARGE Study)
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to understand how genes, environment, and the interplay between the two, influences the development of autism and other neurodevelopmental disorders.
| Condition |
|---|
| Autism Developmental Disabilities |
MedlinePlus related topics: Autism; Developmental Disabilities
Study Type: Observational
Study Design: Screening, Cross-Sectional, Case Control, Retrospective/Prospective Study
Official Title: Environmental Factors in the Etiology of Autism
Expected Total Enrollment: 2000
Study start: September 2001; Expected completion: September 2007
Last follow-up: September 2006; Data entry closure: September 2007
The causes and contributing factors for autism are poorly understood. Evidence suggests that incidence is increasing, but diagnostic changes and improvements may be playing a role. Both genetic and environmental factors appear to play a role. Autopsy studies demonstrate structural changes in the brain and clinical investigations reveal neurophysiologic differences in information processing in autistic versus normal children. Members of our team recently demonstrated altered levels of certain neuropeptides at birth in children who later developed autism.
This case-control study is the first large-scale epidemiologic investigation of underlying causes for autism and triggers of regression. This study capitalizes on the strengths of the case-control design, which is well suited to examine a broad array of factors for rare conditions that are thought to be multifactorial. Comparisons will be made with both general population controls and mentally retarded children.
The aims are to assess the influence of exogenous exposures, the role of susceptibility factors, and the interplay between these two in the etiology of autism and its phenotypic variation. Chemicals with known or suspected neurodevelopmental toxicity, such as PCB’s, certain pesticides, and metals, are being investigated. This study pursues several hypotheses that have recently gained attention, including the combined measles, mumps, rubella vaccine and mercury present in vaccines given during infancy and early childhood. Additionally, biochemical susceptibility is examined through characterization of metabolic, immunologic, and neuronal gene expression profiles and genetic polymorphisms.
Eligibility
Ages Eligible for Study: 24 Months - 60 Months, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Inclusion Criteria:
- Children between 2 and 5 years old
- Born in California
- Parents must speak either English or Spanish
- Children must be living with at least one biologic parent
Exclusion Criteria:
- Children not meeting eligibility criteria listed above
- Children not residing in selected geographical areas (please contact for more information about specific study locations)
Location and Contact Information
California
University of California, Davis, California, 95616, United States; Recruiting
Irva Hertz-Picciotto, MPH, PhD, Principal Investigator
Isaac N. Pessah, Ph.D., Principal Investigator, University of California, Davis
Irva Hertz-Picciotto, Ph.D., Study Director, University of California, Davis
More Information
Record last reviewed: March 2005
Last Updated: March 28, 2005
Record first received: March 28, 2005
ClinicalTrials.gov Identifier: NCT00106652
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005

Not Signed In -


